Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Curr Opin Rheumatol. 2020 Jul;32(4):371–379. doi: 10.1097/BOR.0000000000000713

Figure 1.

Figure 1.

Definition and role of reactive therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease.

PNR: primary non-response, LOR: loss of response; TDM: therapeutic drug monitoring; TNF: tumor necrosis factor.